Introduction
Blood-borne IGF-I is emerging as an unexpected factor in neurotrophic networks in the adult brain. 1 Probably due to its multi-faceted actions on brain cells, 2 serum IGF-I has also been related to cognition. Evidence gathered from human studies shows a positive correlation between serum IGF-I levels and mental abilities, [3] [4] [5] [6] [7] [8] while cognitive impairment has been found in human patients affected by GH/IGF-I deficiency.
9,10 A more direct relationship between IGF-I and cognition is derived from animal experiments showing that administration of IGF-I restores cognition in aging animals, 11, 12 that inhibition of IGF-I action results in cognitive impairment in adult rodents, 13, 14 or that old mice with serum IGF-I deficiency show cognitive impairment. 15 Based on all this evidence, we recently proposed that serum IGF-I contributes to building a 'cognitive reserve', 16 a concept that refers to the availability of functional resources supporting cognition which was originally coined to explain relative resilience to dementia in relation to education level. 17 This purported role of serum IGF-I could help to explain its neuroprotective effects against diverse types of insults 18 and will theoretically support an active role of this circulating growth factor on higher brain functions.
However, evidence in favor of a role of serum IGF-I in brain mechanisms involved in cognitive processes is merely correlative in human studies and, albeit supportive in animals' experiments, more work is needed before we can establish a plausible relationship between serum IGF-I and cognition. In the present study, we have modulated circulating IGF-I levels using a mouse model of serum IGF-I deficiency combined with systemic administration of IGF-I. Our findings indicate that serum IGF-I modulates cognitive abilities due to its trophic effects on glutamatergic synapses.
Materials and methods

Animals
Mice with low-serum IGF-I were generated as described elsewhere by disrupting the liver IGF-I gene (LID mice) with the albumin-Cre/Lox system that starts to be activated at about postnatal day 10. 19 Serum IGF-I-deficient mice have normal body and brain weights and do not show developmental defects. 19, 20 Mutant mice have normal serum IGF-I levels during the first weeks of life (not shown) but soon thereafter liver IGF-I production starts to decline and by 2 months of age LID mice show a B60% decrease in serum IGF-I as compared to control littermates. 21 Tissue levels of IGF-I mRNA, including the brain, are normal 19 (see also below). General health and gross neurological evaluation of the mutant mice, assessed as published elsewhere, 22 showed no difference with controls (Lox þ / þ Cre À littermates). Mice were genotyped by PCR. Adult 2-6 months old male mice were used throughout (specific ages are given in each experiment). In behavioral tests, age-matched wild-type C57BL/6 mice were included as additional controls together with control littermates because they are partially congenic to the original FVB/N breeders (backcrossed in C57BL/6 for seven generations). Animals were kept under standard diet and light/dark conditions following EU guidelines and handled according to institutionally approved procedures.
To determine the effects of IGF-I administration on LID mice, recombinant human IGF-I (GroPep, Adelaide, Australia) was infused (50 mg kg À1 per day, 2-3 weeks) through either subcutaneous osmotic minipumps (Alzet 2002, Alzet Minipumps, Cupertino, CA, USA) or biodegradable IGF-I microspheres. 23 Control groups received saline-filled pumps or blank microspheres, respectively.
Behavioral tests
The ages of the animals used for behavioral testing were 3-to 4-months old animals for Morris water maze, visual discrimination and open-field behavior; 2-3 months for motor learning evaluation. Spatial learning was evaluated using a standard water maze test 24 in a 100 cm wide pool. Room/pool cues consisted of four highly contrasted black plastic pieces of geometric forms for intramaze cues (light gray pool), and four highly contrasted white paper pieces of geometric forms for extramaze cues (dark gray curtains rounding the pool). This methodology is described in detail elsewhere. 18, 25 Briefly, after 1 day habituation trial (day 1) in which preferences between tank quadrants were ruled out, for the subsequent 6 days the animals learned to find a hidden platform (acquisition). The next day, a probe trial without the platform was performed to evaluate preference for the platform quadrant (retention). On the last day, a cued version protocol was conducted to rule out possible sensorimotor and motivational differences between experimental groups. Swimming speed was found to be similar in all groups on all days. All animals were tested in four trials per day using 20 min inter-trial intervals. Individual sums of the four trials for escape latency were obtained previously to obtain the mean escape latency of each group. Path length and swim speed were measured with software EthoVision (Noldus, The Netherlands).
Motor learning was assessed using a rota-rod apparatus (Ugo Basile, Italy) under constant acceleration in six consecutive trials of 5 min as described. 26 Animals were familiarized with the procedure under constant rod speed, 1 day before. A visual discrimination test was performed as described. 27 Briefly, mice were deprived of water for 24 h and trained to distinguish a target cylinder (that is, black vs white non-target cylinders) containing water in a small well, in the absence of olfactory cues. The position of the cylinders is changed randomly during a 10-trial session. The test was performed during 2 consecutive days and results expressed as number of wrong choices before reaching the target. All animals learned the task because they performed significantly better (P < 0.05) during the second day, as compared to day 1. Open-field behavior was assessed by measuring deambulatory activity in a computer-controlled actimeter cage (DigiScan, Omnitech Electronics, Columbus, OH, USA) allowing the animals to move freely for 15 min as described. 26 In vivo electrophysiology Initial recordings were performed in 4-5 months old animals. Next, osmotic minipumps were implanted in animals of the same age during 3 weeks; therefore, the subsequent recordings were made in 5-6 months old animals. Recording electrodes were stereotaxically implanted in the dentate gyrus (A: À2,3; L: 2; H: 1.5 mm from bregma) or neocortex (A: À2.3; L: 2; H: 0.5 mm from bregma) according to the Paxinos atlas. 28 Twisted bipolar electrodes for electrical stimulation were aimed at the perforant path (A: À2.5; L: 0.5; H: 1.5 mm from bregma) or contralateral neocortex (same coordinates). Baseline recordings were taken with test stimuli (100 mA, 0.3 ms, 0.5 Hz) during 20 min before tetanic stimulation consisting of three pulse trains of 100 mA, lasting each pulse 0.3 ms and at 100 Hz. Trains lasted 500 ms and the inter-train interval was 2 s. Recording was maintained for 1 h after tetanic stimulation. Field potentials were amplified (AC Amplifier, WPI, Stevenage, USA), 0.1 Hz-3 kHz band-pass filtered and digitized at 10 kHz (CED 1401 with Spike 2 software, UK). Field potential averages were calculated using 50 stimuli. Baseline values were calculated as the mean from average responses over a 20 and 10 min period before high-frequency stimulation. Recordings were accepted for analysis when baseline variability was less than 10%.
In vitro electrophysiology Hippocampal slices were prepared from 2 to 4 months old LID mice and control littermates. Mice were deeply anesthetized (pentobarbital, 35 mg kg
À1
) and decapitated immediately after disappearance of the pinch reflex. Brain was rapidly removed and submerged in an ice-cold high-sucrose artificial cerebrospinal fluid (aCSF) containing (mM): sucrose 248, KCl 3, NaH 2 PO 4 1.25, NaHCO 3 4 2, ascorbic acid 1 and pyruvic acid 3, pH 7.4. Slices were transferred to a recording chamber and perfused at a rate of 3-6 ml min À1 with aCSF (321C with the same composition as above but without ascorbic and pyruvic acid). Extracellular recordings were made with glass pipettes (2-5 MO) filled with 150 mM NaCl. Pipettes were located on the outer 2/3 of the molecular layer and field-evoked potentials (fEPPs) were elicited by stimulation of the lateral perforant path. Data were acquired using an amplifier (Axoclamp 2B) and low-pass filter at 3 kHz. fEPPs were elicited at 0.05 Hz using a bipolar nichrome electrode during 20-30 min until baseline fEPPs slope was stabilized. Slices with fEPPs slopes of less than 0.5 mV ms À1 were discarded. Long-term potentiation (LTP) was induced by three high-frequency trains of 1 s at 100 Hz, 20 s apart. GABA-A antagonists biccuculine and picrotoxin (10 and 100 mM, respectively, Sigma, St Louis, MO, USA) were used in some experiments.
Immunocytochemistry
Brain tissue for immunohistochemistry was processed from 2 to 4 months old mice immediately after sectioning to obtain confocal images with the quality required for a high magnification. Glutamatergic and GABAergic synapses in the hippocampus were identified by double immunocytochemistry with anti-vesicular glutamate transporter 1 (VGlut1; Chemicon, Millipore, Billerica, MA, USA; 1:5000), a glutamatergic synapse marker, 29 and anti-glutamic acid decarboxylase (GAD6; Developmental Hybridoma Bank, Iowa City, IA, USA; 1:1000), a GABAergic synapse marker, 30 followed by biotinylated (Vector, USA, 1:1000) and Alexa 594-coupled (Molecular Probes, Invitrogen, Carlsbad, CA, USA, 1:1000) secondary antibodies. Biotinylated antibody was detected with Alexa 468-conjugated streptavidin (Molecular Probes, 1:1000). A dedicated set of 1-in-9 series of 50 mm vibratome sections of mice brains was used for the determination of glutamatergic and GABAergic boutons. Measurements were performed in images recorded with a confocal microscope (Leica TCS 4D), using a Â 63 oil objective and a Â 9 zoom. Four sections per animal were used comprising the entire frontal cortex or hippocampus, and one random area in the frontal cortex and the hippocampus per section (see Figure 4a) were measured. Image analysis was performed with AIS software (GE Healthcare, Piscataway, NJ, USA). Briefly, boutons with positive immunofluorescence (either VGlut1 or GAD6 because these markers never colocalize, see Figure 4a ) were measured separately applying the same threshold to all pictures. Images were previously converted to gray scale to improve the contrast between signal and noise. Areas were measured inside a reference circle with a standard size of 325 mm.
2 Reference space was located either in the inner molecular layer of the hippocampal dentate gyrus, lining the most external layer of granule neurons in the GCL, or in the outer portion of layer II of the frontal cortex, lining the most external layer of projection cortical neurons. We first calculated the percentage of reference area occupied by each type of bouton. We then determined the VGlut1/GAD6 ratio, and considering that the two types of boutons do not colocalize we obtained the data of the sum of percentage area occupied by both types of synaptic boutons. Finally, we determined the boutons (VGlut1 only, GAD6 only and the sum)-to-granule neuron number ratio. Data are presented as percentage of control values.
Immunoassays IGF-I and brain-derived neurotrophic factor (BDNF) were measured in 2-4 months old mice. Endogenous IGF-I levels were assayed with an enzyme-linked immunosorbent assay (ELISA) for murine IGF-I using anti-mouse IGF-I antibodies (MAP791 and BAF791, R&D, Minneapolis, MN, USA) and mouse IGF-I (IBT, Germany) as standard (sensitivity of the assay is 0.5 ng ml
À1
). Using this assay, we did not detect human IGF-I in treated animals: mice had identical endogenous serum IGF-I values after human IGF-I treatment (48677 ng ml À1 before and 48674 ng ml À1 after treatment; n = 5-7 per group). Exogenously administered IGF-I (human recombinant IGF-I) was measured after 7-10 days of infusion with a commercial ELISA for hIGF-I (DSL, Webster, TX, USA) following the manufacturer's instructions (sensitivity of 13 ng ml
). In this assay, control wild-type mice receiving blank microspheres had undetectable serum levels of hIGF-I. Hippocampal BDNF levels were measured by a commercial ELISA (Chemicon). The sensitivity of the assay is 7.8 pg ml
. Western-blot and immunoprecipitation were performed as described 21 to determine TrkB and Tyr-phosphorylated TrkB. Anti-TrkB antibodies (Santa Cruz, CA, USA) and anti-pTyr (PY20 clone) were used at 1:1000-2000 dilution. Levels of pTyrTrkB were expressed relative to TrkB load in each lane. Levels in the ELISA assays were expressed relative to total protein levels assessed with the Bradford reagent (Bio-Rad, Hercules, CA, USA) in parallel aliquots. Densitometric analysis was performed using Quantity One software (Bio-Rad). Horseradish peroxidase-coupled secondary antibodies were from Bio-Rad.
RNA quantification IGF-I mRNA was quantified by qPCR using an Applied Biosystems (Foster City, CA, USA) kit as specified by the manufacturer in an ABI Prism 7000 Sequence Detector (Applied Biosystems, Weiterstadt, Germany) in a 20 ml volume reaction. Total RNA was extracted from 3-month-old mouse hippocampi using the Rnaqueous-4PCR kit (Ambion, Austin, TX, USA).
cDNA synthesis was performed by using 100 ng of RNA with High-capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA, USA). TaqMan probes and primers for IGF-I and for the control housekeeping gene, rRNA 18 s, were from the Assay-on-Demand gene-expression products (Applied Biosystems). All TaqMan probes were labeled with 6-carboxy fluorescein (FAM). All reactions were performed in triplicates using the TaqMan Universal PCR Master Mix. The standard curves for IGF-I and rRna 18 s were generated with serial dilutions of the cDNAs from hippocampus (n = 6) of wild-type mice, control littermates and LIDs. Gene expression was normalized for rRNA 18 s levels.
Statistics
Statistical analysis was performed with a t-test when comparing two groups and a two-way analysis of variance (ANOVA) for comparing multiple groups. Post-hoc comparisons were made with a NewmansKeuls' test. Results are shown as means7s.e.m. Water maze results were analyzed with two methods. In the learning curves, escape latencies of all animals across days and groups were compared with repeated measures of ANOVA and post-hoc tests. This allows to analyze if time is a factor influencing the scores across groups. In Figure 1a , representing escape latencies, significant differences between groups are indicated with asterisks. In the probe trials, escape latency scores of the different groups were compared with a one-way ANOVA and post-hoc Tukey's test.
Results
Serum IGF-I and learning and memory
To determine a possible relationship between serum IGF-I and cognitive performance, we tested learning and memory status in low-serum IGF-I (LID) mice. LID mice showed normal motor learning in the rotarod test (Table 1) , while spatial learning was impaired. Young adult LID mice learned significantly worse than age-matched control littermates or wildtype mice in the water maze (F = 104.7, P < 0.0001) as determined by significantly different mean escape latencies (Figure 1a ; P < 0.0001 vs all other groups). LID mice also showed significantly worse memory of the location of the hidden platform as evidenced by a significantly decreased preference for the platform quadrant when animals were tested in the water maze in the absence of platform (Figure 1b , P < 0.05 vs control littermates, probe trials). Probe trials also evidenced a significant difference between wild-type C57BL/6 mice and control littermates in retention of the platform position (Figure 1b , P < 0.05 vs control littermates). Worse spatial memory in control littermates may be attributed to slight differences in genetic background with wild-type mice.
To rule out possible interferences in learning due to sensorimotor impairments, we checked the performance of LID mice in visual discrimination tests and in the cued version of the water maze. In both tasks, LID mice show normal scores as compared to control littermates (Table 1) . To assess the role of circulating IGF-I in cognitive deficits, we chronically treated LID mice with systemic hIGF-I, a procedure that results in increased serum and brain hIGF-I in normal animals. 26 Confirming previous observations, LID mice showed significantly lower endogenous serum levels (P < 0.001 vs wild-type controls and littermates) but normal brain levels (P = 0.06 vs wild types and P = 0.08 vs littermates) of IGF-I as compared to controls (Table 2) . After prolonged infusion with human IGF-I, both LIDs and controls had similar increases in serum and brain hIGF-I levels (Table 3) .
We speculated that spatial learning deficits in LID mice could be related to low-serum IGF-I levels because these mice have normal levels of IGF-I mRNA as compared to wild-type controls and littermates (Table 2) . Also, hippocampal IGF-I protein levels in
Platform quadrant
Rest of quadrants Serum IGF-I and synaptic plasticity To explore possible mechanisms underlying cognitive disturbances in low-serum IGF-I mice, we determined development of LTP in brain synapses of adult LID mice and control littermates. Various forms of synaptic plasticity have been proposed to underlie cognitive processes, and LTP is one of the best characterized (although its ultimate relationship to learning and memory processes remains to be established). We analyzed LTP of the perforant pathgranule cell synapse in the hippocampus and found a complete absence of this synaptic form of plasticity in LID mice. Electrical stimulation of the perforant path at 0.5 Hz evoked a field potential in the granule cell layer with an initial positivity corresponding to the population excitatory postsynaptic potential (EPSP) followed by a negative wave representing the population spike potential (Figure 2a, inset) . In control littermate mice (n = 8), tetanic stimulation (three trains of 500 ms at 100 Hz) elicited a significant potentiation of the population EPSP slope (P < 0.001 vs baseline levels for all points after tetanic stimulation), peaking at 10-30 min and lasting for at least 1 h after stimulation (Figure 2a; 191.3710.6% over baseline levels, 60 min post-tetanus). In LID mice (n = 8), the same LTP protocol failed to produce an increase in the EPSP slope: 76.2710% of pre-stimulus levels after 60 min (Figure 2a) . Further increasing the intensity of the stimulation to 120-150 mA was ineffective (n = 4, not shown). Similarly, tetanus stimulation frequencies of 10-50 Hz did not produce LTP in LID mice either.
Lack of LTP in LID mice is specific for this hippocampal circuitry because neocortical LTP was evoked in LID as well as in control mice. A similar stimulation protocol was applied to callosal fibers and the evoked field potential was recorded in the contralateral neocortex. In this case, electrical stimulation elicited a field potential which consisted in an initial negativity followed by a positive wave (Figure  2b, inset) . Neocortical field potential amplitude in either control littermates (n = 6) or LID mice (n = 6) increased after LTP induction before reaching a stable potentiated level (that is, values similar to those obtained 60 min post-tetanus; Figure 2b ). However, LID mice reached a steady LTP level only after 30 min of tetanus while controls achieved it within 10 min of tetanic stimulation. When LTP was induced in the neocortex and the hippocampus of the same animal, LID mice exhibited LTP in the neocortex but not in the hippocampus (n = 3).
We next determined whether hippocampal LTP in LID mice can be restored by systemic IGF-I Abbreviation: IGF-I, insulin-like growth factor I. a Motor coordination was measured as time (seconds) spent in the rota-rod in the last trial (n = 8 per group). b Visual discrimination was determined by number of errors before correct performance (n = 7). c Horizontal deambulation was measured as horizontal activity (number of beam cuts) in the actimeter (n = 8). d Sensorimotor integration was evaluated using the cued version of the water maze (seconds to reach the visible platform; n = 12). Controls are littermates. All animals were 2-4 months old in this and the following tables. Abbreviation: IGF-I, insulin-like growth factor I. a Levels in ng ml À1 (n = 5-6 per group). b Levels in pg mg À1 protein (n = 15 per group). c Levels in arbitrary densitometric units, determined by qPCR (n = 6 per group). *P < 0.001 vs wild types and littermates. No other significant differences were found. Abbreviation: IGF-I, insulin-like growth factor I. a Levels in ng ml À1 (n = 5-6 per group). b Levels in pg mg À1 protein (n = 8 per group).
Serum IGF-I and cognition Jl Trejo et al administration. Indeed, after chronic treatment (3 weeks) with subcutaneous IGF-I, LID mice exhibited hippocampal LTP: EPSP slopes were larger after tetanic stimulation as compared to baseline values (P < 0.005 vs untreated LID; n = 4, Figure 2a ).
Loss of hippocampal LTP in LID mice: underlying mechanisms
We analyzed possible mechanisms underlying the lack of hippocampal LTP in LID mice using hippocampal slices. We first corroborated the absence of LTP in the perforant path-granule cells pathway in hippocampal slices obtained from LID mice, while control hippocampal slices showed LTP (Figures 3a-c) . We next observed that LTP was brought about in LID hippocampal slices when GABA-A blockers (bicucculine þ picrotoxin) are included in the perfusion medium (Figures 3a, d and e) . As shown in Figure 3d , in the absence of GABA blockers tetanic stimulation did not elicit LTP in LID slices (black dots) but when GABA inhibitors were included in the perfusion bath a second identical tetanus elicited LTP similar to control slices (white dots). Because no delayed potentiation was observed in the presence of GABA blockers (Figure 3d, stage 2 ), it appears that the first tetanus did not produce any form of non-expressed LTP and that GABAergic transmission was not potentiated either. No differences in pulsepaired facilitation between LID and control slices were found (Supplementary Figure 1A) . Application of IGF-I to the bath did not affect the slope of fEPPs in LID or control slices (Supplementary Figure 1B and C) . Moreover, in the presence of IGF-I, tetanus stimulation did not induce LTP in LID slices, indicating that IGF-I does not acutely modulate LTP (not shown).
Serum IGF-I and glutamatergic/GABAergic synapses
Absence of LTP in LID mice may be related to an altered excitatory-inhibitory balance, as suggested by normal LTP in LID hippocampal slices after GABAergic inhibition was blocked. 31 Indeed, assessment of the number of GABAergic (GAD6 þ profiles) and glutamatergic (VGlut1 þ ) boutons in the hippocampal molecular layer of LID mice (Figure 4a) showed a significantly decreased number of VGlut1 þ boutons (Figure 4b ), without changes in GAD6 þ profiles (Figure 4c ), leading to a significantly reduced ratio in glutamate/GABA synapses (Figure 4d , P < 0.05). Notably, the VGlut1 þ /GAD6 þ ratio was not altered in the cortex of LID mice (P = 0.6, layer II, the site where LTP recordings were performed). Other alterations that could account for disrupted hippocampal LTP in LID mice, such as presynaptic changes in the cortico-hippocampal circuitry analyzed or altered levels of BDNF or its receptor (TrkB) in the hippocampus were ruled out. Thus, the number of cells in layer II of the entorhinal cortex, the cortical area projecting to granule neurons through the perforant path was not altered. LID mice have 13 93171048 cells and control littermates 14 60971411 cells (n = 6 per group). Similarly, hippocampal BDNF levels were comparable in LID mice and controls (Table 4) , while levels of phosphorylated TrkB (the active form of the BDNF receptor) were in LID mice 85-94% of wild type and control littermate levels, respectively (not significantly different, see Table 4 and Supplementary Figure 1D) . Administration of IGF-I did not produce any significant alteration in hippocampal BDNF and pTrkB levels as compared to baseline levels in any of the groups (Table 4) .
Thereafter, we treated LID mice with systemic IGF-I for 2 weeks and counted the number of GAD6 þ and VGlut1 þ profiles. We found that IGF-I treatment significantly increased VGlut1 boutons in LID mice leading to a normalization of the glutamate/GABA synapse ratio. No changes in the total number of synapses or in the synapse-to-neuron ratio was observed in LID mice, nor after IGF-I treatment. Representative fEPSP traces before (black trace) and after (green trace) tetanus in slices from control (n = 5) and LID mice (n = 6), respectively. Note that slices from LID mice do not display potentiation. (c) Tetanic stimulation elicited LTP in slices from control (white dots), but not from LID mice (black dots). While fEPSP values before tetanus were similar in both groups, after tetanus only control mice showed sustained enhanced fEPSP values. Tetanus is indicated by the arrow. (d) Perfusion of GABA-A antagonists (bicuculline þ picrotoxin) unmasked the capacity of LID slices to undergo LTP. In the absence of GABA inhibitors LID slices (black dots, n = 4) did not show LTP after tetanic stimulation (first arrow to the left). However, after GABA inhibition, a second tetanus (second arrow) elicited LTP in LID hippocampal slices similar to that obtained in slices from control littermates (white dots, n = 5). (e) Representative fEPSP from LID mice slices at the indicated times (as shown in d): one, before tetanus; two, after the first tetanus; three, before the second tetanus in the presence of GABA-A antagonists and four, after the second tetanus in the presence of GABA-A antagonists. Note that slices from LID mice display potentiation only in the presence of GABA blockers. Abbreviations: BDNF, brain-derived neurotrophic factor; IGF-I, insulin-like growth factor I. a Levels in pg mg À1 tissue (n = 4-6 per group; P = 0.06 LIDs vs littermates, baseline levels). b Levels in arbitrary densitometric units determined by western bolt (WB) and corrected for protein load with total TrkB (n = 4-8 per group; P = 0.3 LIDs vs wild type, baseline levels). c No significant differences in BDNF or pTrkB levels were seen after IGF-I as compared to basal values.
Discussion
The present results suggest that the trophic actions exerted by circulating IGF-I on glutamatergic synapses modulate synaptic LTP within hippocampal circuitries and in this way affect hippocampal learning and memory. These observations agree with previous suggestions of a role of IGF-I on cognition in rodents 11, 13, 14 and provide a mechanistic frame to help understand parallel changes in serum IGF-I levels and cognitive status in humans. [3] [4] [5] [6] [7] [8] If these observations are translated to the human situation, we would anticipate that both in aged humans and in GH/IGF-Ideficient subjects, the number of hippocampal GABAergic and glutamatergic synapses may be imbalanced as compared to young and healthy individuals, which in turn may relate to cognitive disturbances known to occur in both cases. 4, 9 This possibility warrants further study.
These observations add to the wide array of actions exerted by blood-borne IGF-I on brain cells, such as protection against injury, 18, 26, 32, 33 modulation of neuronal excitability 34, 35 brain angiogenesis, 36 hippocampal neurogenesis 37, 38 or amyloid clearance. 21 An important conclusion that is emerging from these findings is that serum IGF-I exerts both relatively fast (within minutes to hours) and slow (within days and weeks) effects on brain function. For instance, neuronal excitability is modulated within minutes after systemic injection of IGF-I, 35 while increases in new hippocampal neurons 37, 38 brain vessels 36 or glutamate synapses (present findings) take weeks. Naturally, we should envisage the biological role of serum IGF-I on brain function as a continuum ranging from acute to long-term effects on brain cells. In this regard, although we cannot yet establish a mechanistic link between acute and long-term actions of IGF-I on glutamatergic transmission, it is tempting to relate its reported acute effects on glutamate receptor function [39] [40] [41] [42] [43] [44] [45] or in intraneuronal Ca 2 þ mobilization [46] [47] [48] to long-term increases produced by IGF-I on glutamatergic receptor levels. 49, 50 At any rate, since pulse-paired facilitation was not modified in LID hippocampal slices, presynaptic alterations may be ruled out, leaving postsynaptic actions of IGF-I as the most likely mechanism involved in its trophic action on glutamatergic transmission.
Other, non-exclusive explanations of the synaptic disturbances seen in serum IGF-I-deficient mice may be inferred from previously characterized long-term actions of this circulating growth factor. For instance, serum IGF-I controls brain amyloid levels. 21 Since amyloid (Ab) reduces glutamatergic transmission 51 through, at least in part, increased internalization of glutamate NMDA receptors without affecting GABA receptors, 52 high levels of brain Ab due to reduced serum IGF-I levels may also lead to reduced glutamatergic synapses and altered LTP. Indeed, the perforant path-granule cell LTP examined in the present work depends on NMDA transmission. 53 This type of process may help explain impaired cognition in aging because age is associated to low-serum IGF-I levels, 54 and to impaired LTP at these synapses. 53 It also may help to explain why successful aging in rats is associated to an increased use of non-NMDA-dependent LTP. 55 In this regard it is important to note that neocortical LTP, albeit slower to develop, was normal in LID mice, suggesting that the effects of serum IGF-I are more evident in given brain areas. However, slower induction of cortical LTP in LID mice could indicate dysregulation in NMDA receptors and/or Ca 2 þ homeostasis at these synapses. Since the number of neocortical glutamatergic boutons was not significantly changed in LID mice, it is probable that altered Ca 2 þ handling in LID neocortical synapses may underlie this delay. At any rate, unveiling the cellular and molecular mechanisms underlying the trophic actions of serum IGF-I on glutamatergic synapses require further studies.
An important additional point that will need further clarification is the role of endocrine and metabolic disturbances associated with low-serum IGF-I levels found in LID mice, such as insulin resistance or high-GH levels. 56 Although IGF-I administration ameliorated learning disturbances and its associated synaptic disturbances, we cannot entirely rule out whether metabolic/endocrine abnormalities associated with IGF-I deficiency may contribute or even be the cause of cognitive impairment in LID mice; even more if one considers the connection between insulin insensitivity and cognitive disturbances, 57 or the possible actions of GH on hippocampal function. 58 However, a direct correlation between serum IGF-I levels and insulin sensitivity, 59 and a feedback effect of IGF-I on GH levels, makes it difficult to separate metabolic disturbances due to IGF-I deficiency from impaired tropism. In addition, because IGF-I is able to stimulate, albeit at lower affinity, the insulin receptor and insulin has procognitive effects of its own, 60 we cannot entirely discard a possible insulin-mimicking activity of IGF-I therapy on LID mice.
The present study also leaves open two intriguing points. Firstly, the observed differences between control littermates and wild-type C57BL/6 mice in the retention phase of the water maze test, while other parameters potentially associated to learning mechanisms such as hippocampal LTP were similar in both strains. As explained above, the strain where the LID mouse is bred is partially congenic with the C57BL/6 strain, and for this reason we included the latter as an additional control group in our study. Inter-strain differences in water maze performance and LTP have been documented in laboratory rodents 61 and these have been started to be characterized at the protein level, 62 which may help explain our observations, although more studies are warranted to clarify these differences. Second, while in the present experiments we did not find any difference between basal BDNF/ pTrkB levels and those after prolonged administration of IGF-I, a functional association between IGF-I and BDNF has been found. Thus, basal BDNF mRNA levels in the hippocampus, 63 as well as exerciseinduced increases in BDNF protein are abrogated by infusion of an anti-IGF-I blocking antibody, 64 while acute injection of IGF-I stimulates forebrain BDNF mRNA in a fashion reminiscent of an acute bout of exercise. 34 The most parsimonious explanation for these apparent inconsistencies is that chronic low availability of IGF-I impinges on basal levels of brain BDNF, while an abrupt increase in IGF-I availability, perhaps resembling an exercise bout, is also able to produce an abrupt increase in BDNF. Conversely, an adaptive mechanism may likely impede that a prolonged increase in IGF-I availability will result in a permanent increase in BDNF levels. However, to determine this putative homeostatic process would require additional studies.
In summary, our findings add a new neuroactive role for circulating IGF-I and provide an explanation for previous observations correlating serum IGF-I levels and cognitive status in humans.
